CELETTI, ANGELA
 Distribuzione geografica
Continente #
AS - Asia 1.098
NA - Nord America 541
EU - Europa 272
SA - Sud America 192
AF - Africa 15
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.121
Nazione #
US - Stati Uniti d'America 510
SG - Singapore 462
CN - Cina 268
BR - Brasile 144
HK - Hong Kong 114
VN - Vietnam 101
IT - Italia 73
KR - Corea 57
FR - Francia 54
NL - Olanda 47
GB - Regno Unito 20
JP - Giappone 20
DE - Germania 19
BD - Bangladesh 18
MX - Messico 18
FI - Finlandia 17
IN - India 14
AR - Argentina 13
CA - Canada 9
EC - Ecuador 9
ID - Indonesia 8
IL - Israele 8
IQ - Iraq 6
PY - Paraguay 6
CL - Cile 5
CO - Colombia 4
NP - Nepal 4
PL - Polonia 4
RU - Federazione Russa 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AT - Austria 3
BO - Bolivia 3
ES - Italia 3
GR - Grecia 3
KE - Kenya 3
PE - Perù 3
TN - Tunisia 3
UA - Ucraina 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
PK - Pakistan 2
PT - Portogallo 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
TR - Turchia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.121
Città #
Singapore 250
Santa Clara 201
Hong Kong 111
Hefei 106
San Jose 66
Seoul 56
Beijing 51
Lauterbourg 45
Los Angeles 35
Ashburn 29
Ho Chi Minh City 28
Hanoi 27
São Paulo 18
Dallas 16
Helsinki 16
New York 13
Marigliano 10
Atlanta 8
Denver 8
Frankfurt am Main 8
Minamishinagawa 8
Naples 7
Tokyo 7
Buffalo 6
Mexico City 6
Ninh Bình 6
Bengaluru 5
Dhaka 5
Haiphong 5
Milan 5
Orem 5
Querétaro 5
Düsseldorf 4
Manchester 4
Montreal 4
Santo André 4
Warsaw 4
Belo Horizonte 3
Biên Hòa 3
London 3
Nuremberg 3
Osaka 3
Porto Alegre 3
Seattle 3
Sóc Trăng 3
Tashkent 3
Vũng Tàu 3
Anápolis 2
Assago 2
Baghdad 2
Baku 2
Bandung 2
Bari 2
Bexley 2
Calgary 2
Campinas 2
Campos dos Goytacazes 2
Can Tho 2
Cape Town 2
Caracas 2
Charlotte 2
Chicago 2
Chisinau 2
Da Nang 2
Dublin 2
Falkenstein 2
Formosa 2
Goiânia 2
Guayaquil 2
Hyderabad 2
Hải Dương 2
Itabira 2
Johannesburg 2
Joinville 2
Kathmandu 2
Kyiv 2
La Paz 2
Lima 2
Luxembourg 2
Machala 2
Manaus 2
Poplar 2
Quito 2
Quận Một 2
Rio de Janeiro 2
Rome 2
Salvador 2
San José 2
Santiago 2
Sorocaba 2
Stockholm 2
Surabaya 2
São José 2
Terzigno 2
Volta Redonda 2
Washington 2
Zurich 2
Acharnes 1
Addis Ababa 1
Al Kazimiyah 1
Totale 1.325
Nome #
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 82
Expression of the RET receptor tyrosine kinase and GDNF-Ra in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow mic 72
The between now and then of lung cancer chemotherapy and immunotherapy 72
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma 72
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology 67
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer 58
CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1 57
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents 56
Epigenetic Mechanisms: Histone Acetylation, DNA Methylation, miRNA, Chromatin Modifiers 53
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options 53
CCDC6: The identity of a protein known to be partner in fusion 52
New therapeutic perspectives in CCDC6 deficient lung cancer cells 51
SELECTION OF ACTIVATING MUTATIONS OF C-FMS IN FDC-P1 CELLS 49
Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: The rationale for their inclusion in the clinic 49
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment 48
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells. 48
Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer 48
NSCLC Mutated Isoforms of CCDC6 Affect the Intracellular Distribution of the Wild Type Protein Promoting Cisplatinum Resistance and PARP Inhibitors Sensitivity in Lung Cancer Cells. 48
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 47
Nucleotide Excision Repair and head and neck cancers. 46
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma 46
Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives 46
Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. 46
CAF-1 subunits levels suggest combined treatments with PARP-inhibitors and ionizing radiation in advanced HNSCC 45
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. 44
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors 41
Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. 40
FKBP51 immunohistochemical expression: A new prognostic biomarker for OSCC? 40
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors. 40
H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization. 39
Analysis of codherin/catenin complexes in transformed thyroid epithelial cells: Modulation by beta 1 integrin subunit 39
Epigenetics of oral and oropharyngeal cancers (Review) 38
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. 37
H4 (D10S170), un gene frequentemente riarrangiato con RET nei carcinomi papilliferi tiroidei: caratterizzazione funzionale. 36
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. 36
L'osteopontina: un nuovo marcatore biologico dei carcinomi della testa e del collo 33
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. 33
Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity. 33
CCDC6 (coiled-coil domain containing 6) 29
HOMEOBOX-CONTAINING GENES AS MOLECULAR MARKERS IN HEMATOPOIESIS 28
Expression Signature 28
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage, 28
Low frequency of p53 mutations in human thyroid tumors: p53 and Ras mutation in two aut of fifty-six thyroid carcinomas 27
Repression of stress-induced apoptosis by the H4(D10S170) 27
Novel Markers for Diagnosis and Prognosis of Oral Intraepithelial Neoplasia 27
Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity 26
³Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage² 25
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. 25
CHARACTERISTIC PATTERNS OF HOX GENE-EXPRESSION IN DIFFERENT TYPES OF HUMAN LEUKEMIA 23
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer. 21
Totale 2.154
Categoria #
all - tutte 6.475
article - articoli 5.764
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 425
Totale 12.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202415 0 0 0 0 0 0 0 0 2 0 13 0
2024/2025867 2 5 64 34 192 47 14 83 33 69 168 156
2025/20261.272 73 144 108 198 266 52 181 58 51 89 52 0
Totale 2.154